Tumour endothelial markers;Śródbłonkowe markery nowotworowe

Wspolczesna Onkologia

Volumn 12, Issue 6, 2008, Pages 255-260

  Kopczyńska, Ewa ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Endothelial cell markers; Tumour markers

Indexed keywords

ENDOSIALIN; MEMBRANE RECEPTOR; TUMOR ENDOTHELIAL MARKER 2; TUMOR ENDOTHELIAL MARKER 3; TUMOR ENDOTHELIAL MARKER 4; TUMOR ENDOTHELIAL MARKER 5; TUMOR ENDOTHELIAL MARKER 6; TUMOR ENDOTHELIAL MARKER 7; TUMOR ENDOTHELIAL MARKER 8; TUMOR ENDOTHELIAL MARKER 9; TUMOR MARKER; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; COLON CANCER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; NEOPLASM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; TUMOR GROWTH;

EID: 67149088477     PISSN: 14282526     EISSN: 14282526     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-62.
2. Rak J, Yu JL, Kerbel RS, Coomber BL. What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors? Cancer Res 2002; 62: 1931-4.
3. Folkman J. Angiogenesis and angiogenesis inhibition. EXS 1997; 79: 1-8.
4. Ribatti D. The involvement of endothelial progenitor cells in tumor angiogenesis. J Cell Mol Med 2004; 8: 294-300.
5. Hristov M, Erl W, Weber PC. Endothelial progenitor cells. Mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003; 23: 1185-9.
6. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 2000; 105: 17-9.
7. St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science 2000; 289: 1197-201.
8. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001; 61: 6649-55.
9. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JAT. Identification of the cellular receptor for anthrax toxin. Nature 2001; 414: 225-9.
10. Werner E, Kowalczyk AP, Faundez V. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J Biol Chem 2006; 281: 23227-36.
11. Scobie HM, Rainey JA, Bradley KA, Young JA. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. PNAS 2003; 100: 5170-4.
12. Bonuccelli G, Sotgia F, Frank PG, et al. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Am J Physiol Cell Physiol 2005; 288: 1402-10.
13. Rainey GJ, Wigelsworth DJ, Ryan PL, Scobie HM, Collier RJ, Young JAT. Receptor-specific requirements for anthrax toxin delivery into cells. PNAS 2005; 102: 13278-83.
14. Nanda A, Carson-Walter EB, Seaman S, et al. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res 2004; 64: 817-20.
15. Rmali KA, Puntis MCA, Jiang WG. Prognostic values of tumor endothelial markers in patients with colorectal cancer. J Gastroenterol 2005; 11: 1283-6.
16. Rmali KA, Watkins G, Harrison G, Parr C, Punits MC, Jiang WG. Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression. Eur J Surg Oncol 2004; 30: 948-53.
17. Davies G, Rmali KA, Watkins G, Mansel RE, Mason MD, Jiang WG. Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance. Int J Oncol 2006; 29: 1311-7.
18. Koo HM, VanBrocklin M, McWilliams MJ, Leppla SH, Duesbery NS, Woude GF. Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. PNAS 2002; 99: 3052-7.
19. Rouleau C, Menon K, Boutin P, et al. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution. Int J Oncol 2008; 32: 739-48.
20. Duesbery NS, Resau J, Webb CP, Koochekpour S, Koo HM, Leppla SH, Woude GF. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. PNAS 2001; 98: 4089-94.
21. Chen KH, Liu S, Bankston LA, Liddington RC, Leppla SH. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells. J Biol Chem 2007; 282: 9834-45.
22. Rogers MS, Christensen KA, Birsner AE, et al. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth. Cancer Res 2007; 67: 9980-5.
23. Duan HF, Hu XW, Chen JL, et al. Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8. J Natl Cancer Inst 2007; 99: 1551-5.
24. Liu S, Wang H, Currie BM, et al. Matrix metalloproteinases anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem 2008; 283: 529-40.
25. Nanda A, St Croix B. Tumor endothelial markers: new targets for cancer therapy. Curr Opin Oncol 2004; 16: 44-9.
26. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci USA 1992; 89: 10832-6.
27. Christian S, Ahorn H, Koehler A, et al. Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem 2001; 276: 7408-14.
28. Opavsky R, Haviernik P, Jurkovicova D, et al. Molecular characterization of the mouse TEM1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem 2001; 276: 38795-807.
29. Im DS. Orphan G protein-coupled receptors and beyond. Jpn J Pharmacol 2002; 90: 101-6.
30. Tomkowicz B, Rybinski K, Foley B, et al. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. PNAS 2007; 104: 17965-70.
31. Nanda A, Karim B, Peng Z., et al. Tumor endothelial marker 1 (TEM1) functions in the growth and progression of abdominal tumors. PNAS 2006; 103: 3351-6.
32. Simonavicius N, Robertson D, Bax DA, Jones C, Huijbers IJ, Isacke CM. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 2008; 21: 308-15.
33. Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, Augustin HG. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol 2008; 172: 486-94.
34. Becker R, Lenter MC, Vollkommer T, Boos AM, Pfaff D, Augustin HG, Christian S. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis - related protein Mac-2 BP/90K. FASEB J 2008; 22: 3059-67.
35. Nanda A, Buckhaults P, Seaman S, et al. Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res 2004; 64: 8507-11.
36. Fuchs B, Mahlum E, Halder C, et al. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene 2007; 399: 137-43.
37. Vallon M, Essler M. Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta3 to glycosaminoglycans. J Biol Chem 2006; 281: 34179-88.